Inify Laboratories is building its first histopathology laboratory in Stockholm, Sweden. Our pathologists and personnel will be supported by state-of-the-art information systems, such as a proprietary AI-based pathology decision support tool, the Inify pathology workstation with structured reporting, and a tailor-made laboratory process support system.
Join our R&D team!
The R&D team of Inify Laboratories will continually improve the digital tools using an agile devops process. Together with the medical and laboratory staff, as well as external partners, they will also participate in research activities to further the state of the art of digital pathology.
We are now looking for new people to join our R&D team.
From 21 to 7 days for biopsy results
Since we started sending our samples to Inify Laboratories, we have gone from a median time of 21 days between biopsy procedure and presenting results to the patient, to being able to schedule follow-ups after just 7 calendar days. Inify’s short and reliable response times also allow us to work more efficiently, as we no longer need to reschedule patients whose test results have not arrived in time. In 100% of the cases, Inify Laboratories has delivered test results within 5 working days.
A sneak peek at the National Prostate Cancer Registry, NPCR, shows that our own fulfilment of the national goal of 11 days for delivery of patient results has improved dramatically, and is now in a league of its own. During 2022 we gave patients their results in time in 2% of the cases while the Swedish average was 11%. Today, we are at 79%, a fantastic number considering that there are always cancellations and reschedulings due to illness or other commitments on the patient’s part.
A sneak peek at the National Prostate Cancer Registry, NPCR, shows that our own fulfilment of the national goal of 11 days for delivery of patient results has improved dramatically, and is now in a league of its own. During 2022 we gave patients their results in time in 2% of the cases while the Swedish average was 11%. Today, we are at 79%, a fantastic number considering that there are always cancellations and reschedulings due to illness or other commitments on the patient’s part.
”During 2022 we gave patients their results in time in 2% of the cases while the Swedish average was 11%. Today, we are at 79%, a fantastic number considering that there are always cancellations and reschedulings due to illness or other commitments on the patient’s part”
We have had a dialogue with Inify Laboratories from the start and appreciate their responsiveness to our needs. We have developed the pathology request and report together and we are incredibly satisfied with the result. The report’s graphic overview clearly shows where positive findings are located, accompanied by a table with more details about each biopsy core. As an operator, it is easy to get a complete decision basis for surgical planning.
We are happy and proud of what we have accomplished through our partnership with Inify. They have truly improved our clinical work. Patients now benefit from a planned process with minimized waiting times, which in turn reduces worry and anxiety about the test results.
We are happy and proud of what we have accomplished through our partnership with Inify. They have truly improved our clinical work. Patients now benefit from a planned process with minimized waiting times, which in turn reduces worry and anxiety about the test results.
”Patients now benefit from a planned process with minimized waiting times, which in turn reduces worry and anxiety about the test results.”